This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Thiesen, J. Articles by Krämer, I. Search for Related Content PubMed Articles by Thiesen, J. Articles by Krämer, I. Social Bookmarking                         What's this?

Physicochemical stability of irinotecan injection concentrate and diluted infusion solutions in PVC bags

Department of Pharmacy, Johannes Gutenberg University Hospital, Mainz, Germany

Irene Krämer, PhD

Department of Pharmacy, Johannes Gutenberg University Hospital, Mainz, Germany

Purpose. To determine the physicochemical stability of irinotecan injection concentrate and irinotecan infusion solutions after dilution in two commonly used infusion fluids (0.9% sodium chloride, 5% dextrose) in PVC bags, stored under refrigeration (2-8°C) or at room temperature either light protected or exposed to light.

Methods. Stability of irinotecan injection concentrate was determined in the original amber glass vials. Diluted irinotecan infusion solutions were aseptically prepared by further dilution of irinotecan stock solution with either 0.9% sodium chloride or 5% dextrose in PVC bags, in amounts yielding irinotecan concentrations of 0.4, 1.0, or 2.8 mg/ml. Test solutions were stored under refrigeration (2-8°C) or at room temperature either light protected or exposed to light (mixed daylight and normal laboratory fluorescent light) in parallel. Irinotecan concentrations were determined periodically throughout a 4-week storage period via a stability-indicating HPLC assay with ultraviolet detection. In addition, measurements of pH values were performed regularly and test solutions were visually examined for colour change and precipitation.

Results. Irinotecan injection concentrate and infusion solutions are shown to be physicochemically stable (at a level of >90% irinotecan) for 4 weeks when stored under refrigeration or light protected at room temperature, independent of the vehicle (0.9% sodium chloride, 5% dextrose) or the concentration (0.4, 1.0, or 2.8 mg/ml). Irinotecan infusion solutions exposed to daylight exhibited concentration-dependent instability, solutions were stable for only 7 to 14 days.

Conclusions. Irinotecan injection concentrate and diluted infusion solutions are shown to have adequate physicochemical stability for convenient pharmacy-based centralized preparation.

Key Words: Irinotecan • infusion solution • injection concentrate • physicochemical stability • photodegradation • PVC bag

Journal of Oncology Pharmacy Practice, Vol. 6, No. 3, 115-121 (2000)
DOI: 10.1177/107815520000600305


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?